UH Seidman Cancer Center

Patients with blood cancers have an 80-percent complete or partial remission rate with our CAR T-cell therapy.

Because of this discovery, we are finding promising therapies and innovative approaches to treat this aggressive cancer.

Radiation therapy used to take many hours. New technology allows us to deliver precise treatments in a few minutes.

Using the latest technology, our team uses fewer and shorter treatments, including just five treatments for prostate cancer.

Three recent medical breakthroughs are helping provide treatment options for patients with pancreatic cancer.

For more than 45 years, we have performed over 3,500 stem cell transplants. We have pioneered many clinical trials to advance transplant methods.

By creating a mass of tens of millions of cells, we can study how brain tumors survive and develop therapies to destroy them.

We create custom 3D-printed implants to help patients regain function, when a return to activities might not have been possible.

We are the first in Northeast Ohio to offer contrast enhanced mammography for women who cannot have an MRI.

We discovered that HPV type 33 is associated with aggressive disease progression for up to 25 percent of patients with HPV-positive oropharyngeal cancer.

For patients with a type of colorectal cancer (dMMR/MSI-H) that cannot be treated with surgery, immunotherapy is now an option and tolerated well in over 90 percent of patients.